why choose us

First received: May 12, 2024

Clinical Trial: Efficacy of Dihydroartemisinin for Treating PCOS

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Polycystic Ovary Syndrome

Study Type: INTERVENTIONAL


Official Title: Therapeutic Efficacy of Dihydroartemisinin in Patients With Polycystic Ovary Syndrome

Brief Summary: The primary research hypothesis of this study is that dihydroartemisinin is effective in restoration of regular menstrual cycles of PCOS subjects who meet at least two of three Rotterdam Criteria.Secondary research hypotheses include: dihydroartemisinin is also effective in reducing androgen, total immature follicles, and anti-Mullerian hormone.

Read more